Active Ingredient History
Tenofovir alafenamide, sold under the brand name Vemlidy, is an antiviral medication used against hepatitis B and HIV. It is used for the treatment of chronic hepatitis B virus (HBV) infection in adults with compensated liver disease and is given in combination with other medications for the prevention and treatment of HIV. It is taken by mouth. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Combination drugs
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Alveolar Bone Loss (Phase 4)
Anesthesia and Analgesia (Early Phase 1)
Antiretroviral Therapy, Highly Active (Phase 4)
Art (Phase 4)
Arthritis (Phase 4)
Body Weight Changes (Phase 3)
Bone Diseases, Metabolic (Phase 4)
Buprenorphine (Phase 4)
Coinfection (Phase 4)
Coronary Artery Disease (Phase 4)
COVID-19 (Phase 3)
Drug Evaluation (Phase 4)
Drug Misuse (Phase 4)
Drugs, Investigational (Phase 4)
Fasting (Phase 3)
Fatigue (Phase 2)
Fatty Liver (Phase 4)
Harm Reduction (Phase 4)
Health Personnel (Phase 3)
Healthy Volunteers (Phase 1)
Hepatitis B (Phase 4)
Hepatitis B, Chronic (Phase 4)
Hepatitis B virus (Phase 4)
Hepatitis C (Phase 4)
Hepatitis C, Chronic (Phase 4)
Hepatitis D (Phase 2)
Hepatitis D, Chronic (Phase 2)
Herpes Simplex (Phase 1)
HIV (Phase 4)
HIV-1 (Phase 4)
HIV Seropositivity (Phase 3)
Hormones (Phase 4)
Immunosuppression Therapy (Phase 4)
Insulin Resistance (Phase 1)
Integrase Inhibitors (Phase 2)
Kidney Transplantation (Phase 4)
Leukemia, Lymphoid (Phase 2)
Liver Cirrhosis (Phase 4)
Liver Diseases (Phase 4)
Liver Failure (Phase 4)
Liver Transplantation (Phase 4)
Lung Transplantation (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Medication Adherence (Phase 3)
Menopause (Phase 4)
Metabolic Syndrome (Phase 3)
Methadone (Phase 4)
Minority Health (Phase 3)
Multiple Sclerosis, Relapsing-Remitting (Phase 2)
Neoplasms (Phase 3)
Obesity (Phase 4)
Opioid-Related Disorders (Phase 4)
Osteoporosis (Phase 4)
Patient Acceptance of Health Care (Phase 2)
Pre-Exposure Prophylaxis (Phase 3)
Pregnancy (Phase 2)
Renal Insufficiency (Phase 4)
Renal Insufficiency, Chronic (Phase 4)
Safety (Phase 4)
Sexually Transmitted Diseases (Phase 4)
Tenofovir (Phase 4)
Treatment Adherence and Compliance (Phase 3)
Tuberculosis (Phase 4)
Tuberculosis, Pulmonary (Phase 2)
Virus Diseases (Phase 4)
Weight Gain (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue